Lombard Odier Asset Management (Usa) Corp Midatech Pharma PLC Transaction History

Lombard Odier Asset Management (Usa) Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$1.68 - $2.19 $496,440 - $647,145	-295,500 Reduced 50.0%	295,500 $382,000
Q2 2021 Aug 13, 2021	BUY	$1.78 - $2.95 $347,990 - $576,725	195,500 Added 49.43%	591,000 $1.06 Million
Q1 2021 May 17, 2021	BUY	$1.92 - $3.8 $759,360 - $1.5 Million	395,500 New	395,500 $611,000

Ticker MTP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,939,740
Market Cap $512K
Description
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant ...

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.